Recent Updates
Recently added Catalysts
VRTX Positive Sentiment

Vertex to Participate in Upcoming September Investor Conferences

Key Takeaway: Vertex Pharmaceuticals has announced its participation in four upcoming investor conferences, highlighting its commitment to investor engagement. Senior Vice President Susie Lisa and Executive Director Manisha Pai will lead discussions at notable events, including the Wells Fargo 21st Annual Healthcare Conference. This proactive approach reflects the company's transparency and confidence in its future.
Price reaction · baseline $547.29 (2026-08-26 close) · hit after-hours · clean, no other VRTX news in the window
day 0 close
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • Vertex Pharmaceuticals is actively engaging with investors.
  • Participation in multiple conferences showcases company transparency.
  • Management's involvement indicates confidence in future prospects.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+31%
120-day peak, hindsight
Typical move
1.7%
average across 15 past catalysts
Lead asset
VX-880
Phase 3 · Diabetes Mellitus, Type 1

Full Press Release Details

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated(Nasdaq: VRTX) today announced management participation in four upcoming investor conferences.
• Susie Lisa, Senior Vice President of Investor Relations and Manisha Pai, Executive Director of Investor Relations, will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 4:30 p.m. EDT.
• Susie Lisa and Manisha Pai will also participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Thursday, September 10, 2026, at 2:10 p.m. EDT.
• Reshma Kewalramani, M.D., CEO and President, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026, at 7:00 a.m. EDT.
• Susie Lisa and Miroslava Minkova, Executive Director of Investor Relations, will participate in a fireside chat at the Bank of America Global Healthcare Conference London on Wednesday, September 23, 2026, at 10:05 a.m. GMT/5:05 a.m. EDT.
A live webcast of management's remarks will be available through the Vertex website,www.vrtx.com, in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including IgA nephropathy, neuropathic pain, APOL1-mediated kidney disease, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, generalized myasthenia gravis, and myotonic dystrophy type 1.
Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 16 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visitwww.vrtx.comor follow us onLinkedIn,Facebook,Instagram,YouTubeandX.
(VRTX-WEB)
Vertex Pharmaceuticals IncorporatedInvestors:InvestorInfo@vrtx.com

Frequently Asked Questions

Which investor conferences will Vertex participate in?

Vertex will participate in four upcoming investor conferences, including the Wells Fargo Healthcare Conference.

Who will represent Vertex at the conferences?

Susie Lisa and Manisha Pai will represent Vertex at the investor conferences.

When is the Wells Fargo Healthcare Conference?

The Wells Fargo 21st Annual Healthcare Conference is scheduled for September 9, 2026.

What is the purpose of these conferences?

These conferences aim to enhance investor engagement and provide insights into the company's future.

Last updated: Aug 26, 2026